Epigenomics AG (EPGNF)
OTCMKTS · Delayed Price · Currency is USD
1.120
+0.170 (17.89%)
At close: Jul 18, 2025
Epigenomics AG Market Cap
Epigenomics AG has a market cap or net worth of $894.11 thousand as of September 12, 2025. Its market cap has increased by 44.28% in one year.
Market Cap
894.11K
Enterprise Value
13.34M
Revenue
4.70K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.12
Market Cap Chart
Since September 22, 2014, Epigenomics AG's market cap has decreased from 66.74M to 894.11K, a decrease of -98.66%. That is a compound annual growth rate of -32.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 894.11K | -12.08% |
| Dec 30, 2024 | 1.02M | -42.03% |
| Dec 29, 2023 | 1.75M | -75.69% |
| Dec 30, 2022 | 7.22M | -22.11% |
| Dec 30, 2021 | 9.27M | -60.80% |
| Dec 30, 2020 | 23.64M | -65.05% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 739.21M |
| Elite Pharmaceuticals | 737.49M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |